﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/zydus-receives-tentative-approval-from-the-usfda-for-dexamethasone-tablets-usp-1-mg-15256</loc><lastmod>2024-02-10T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/biocon-biologics-partners-with-sandoz-australia-for-biosimilars-trastuzumab-and-bevacizumab-15257</loc><lastmod>2024-02-10T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/max-healthcare-announces-acquisition-of-jci-accredited-200-bedded-alexis-hospital-nagpur-15258</loc><lastmod>2024-02-10T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/zydus-lifesciences-q3-fy24-pat-up-268-15259</loc><lastmod>2024-02-10T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>